$285.89
-7.75-2.64%
Pre-Market: Jan 17, 6:48 PM EDT
Comments
Loading...
Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock, Earnings Estimates, EPS, And Revenue
Madrigal Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 26
EPS Estimate
$-4.360
Quarterly Revenue Estimate
$91.25M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$76.81M
Analyze the earnings history of Madrigal Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Madrigal Pharmaceuticals (MDGL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-10-31 | $-4.92 | $-6.91 | 28.8 % |
| Q2 | 2024-08-07 | $-7.10 | $-7.54 | 5.84 % |
| Q1 | 2024-05-07 | $-7.38 | $-6.28 | -17.5 % |
| Q4 | 2024-02-28 | $-5.68 | $-5.28 | -7.58 % |
Madrigal Pharmaceuticals (MDGL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-10-31 | $62.18M | $34.19M | 81.8 % |
| Q2 | 2024-08-07 | $14.64M | $4.02M | 264.1 % |
FAQ
When is Madrigal Pharmaceuticals (NASDAQ:MDGL) reporting earnings?
Madrigal Pharmaceuticals (MDGL) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on October 31, 2024 for Q3.
What were the latest earnings per share (EPS) for Madrigal Pharmaceuticals (NASDAQ:MDGL)?
The Actual EPS was $-4.92, which beat the estimate of $-6.91.
What were Madrigal Pharmaceuticals’s (NASDAQ:MDGL) revenues?
The Actual Revenue was $62.2M, which beat the estimate of $34.2M.
Browse earnings estimates, EPS, and revenue on all stocks.